NCT05609123 Endothelial Glycocalyx Damage in Brain Death Organ Donors
| NCT ID | NCT05609123 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Hradec Kralove |
| Condition | Brain Damage Due to Hypoxia |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-01-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2022-01-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims the assessment of endothelial glycocalyx (EG) degradation in deceased organ donors. There is a lack of organs for the transplantation program. By the description of the EG status, we can open room for organ optimization before transplantation and improve the organ function after transplantation in marginal donors.
Eligibility Criteria
Inclusion Criteria: * patients in critical condition declared as brain dead by clinical examination Exclusion Criteria: * N/A
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05609123 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Brain Damage Due to Hypoxia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05609123 currently recruiting?
Yes, NCT05609123 is actively recruiting participants. Contact the research team at david.astapenko@fnhk.cz for enrollment information.
Where is the NCT05609123 trial being conducted?
This trial is being conducted at Hradec Králové, Czechia.
Who is sponsoring the NCT05609123 clinical trial?
NCT05609123 is sponsored by University Hospital Hradec Kralove. The trial plans to enroll 100 participants.